02257 聖諾醫藥－Ｂ
按盤價 
9.870 +0.260 (+2.706%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 資產回報率 (%) | -98.703% | -65.653% | -43.650% | -121.466% | -64.844% |
| 股東資金回報率 (%) | -266.814% | -97.028% | -52.934% | -363.658% | N/A |
| 資本運用回報率 (%) | N/A | -244.968% | -58.982% | -94.943% | -272.129% |
邊際利潤分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 67.435% | N/A | N/A | N/A | N/A |
| 未計利息、稅項、折舊及攤銷前利潤率 (%) | -2457.593% | N/A | N/A | N/A | N/A |
| 稅前邊際利潤率 (%) | -2825.928% | N/A | N/A | N/A | N/A |
| 純利率 (%) | -2889.933% | N/A | N/A | N/A | N/A |
變現能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流動比率 (X) | 0.523 X | 1.345 X | 8.241 X | 13.791 X | 1.117 X |
| 速動比率 (X) | 0.523 X | 1.345 X | 8.241 X | 13.791 X | 1.117 X |
財務槓桿分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 總負債 / 總資產比率 (%) | 156.493% | 67.729% | 31.947% | 12.616% | 185.475% |
| 總債項 / 總資產比率 (%) | 28.444% | 11.671% | 6.561% | 2.925% | 2.615% |
| 淨債項 / 總資產比率 (%) | -13.100% | -19.844% | -57.630% | -85.168% | -90.976% |
| 總債項 / 股東資金比率 (%) | N/A | 22.005% | 8.816% | 3.327% | N/A |
| 長期債項 / 股東資金比率 (%) | N/A | 19.072% | 7.381% | 2.691% | N/A |
| 淨債項 / 股東資金比率 (%) | N/A | -37.414% | -77.433% | -96.852% | N/A |
| 淨現金 / (債項) ($) | 3.71百萬 | 1.50千萬 | 9.45千萬 | 2.05億 | 1.00億 |
| 每股淨現金 / (債項) ($) | 0.035 | 0.172 | 1.074 | 2.327 | -- |
| 總債項 / 資本運用比率 (%) | N/A | 27.535% | 7.185% | 3.137% | 17.911% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
營運效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存貨周轉率日數 (日) | N/A | N/A | N/A | N/A | N/A |
| 應收貿易帳周轉率日數 (日) | N/A | N/A | N/A | N/A | N/A |
| 應付貿易帳周轉率日數 (日) | 869.082日 | N/A | N/A | N/A | N/A |
| 備註： | 即時報價更新時間為31/10/2025 17:59 |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
| 股東應佔溢利/(虧損) (千) | USD -3,698 |
| 增長率 | -90.995% |
| 每股盈利/(虧損) | USD -0.040 |
| 每股帳面資產淨值 ($) | USD -0.049 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
